We compared three methods of administering metaraminol during spinal (subarachnoid) anaesthesia. Fifty-two elderly patients with fractured hips were studied. Blood pressure was maintained by either intramuscular (IM) metaraminol (0.1 mg.kg -1 ), intravenous (IV) boluses (0.01 mg.kg -1 ) or an infusion (0.05 mg.kg -1 .h -1 ). Noninvasive blood pressure was recorded every one-minute.
Hypotension is a major problem when performing spinal (subarachnoid) anaesthesia, especially in the elderly hip fracture patient, in whom severe episodes are common and in whom coronary and cerebral ischaemia may result 1, 2 . Current recommendations regarding treatment are to administer moderate volumes of intravenous (IV) fluid to counter venous dilatation and vasopressors to restore blood pressure to acceptable levels [1] [2] [3] [4] . In elderly patients peripheral vasoconstrictors, such as metaraminol or methoxamine, are preferred over ephedrine. Ephedrine has mixed peripheral vasoconstrictor and cardiac stimulatory actions, but tends to be ineffective and causes unwanted tachycardia 5 .
The question of how to administer vasopressors to obtain optimal results has not been fully addressed. Intravenous boluses of vasopressor are easily administered but tend to be unpredictable and shortlived in action 6 . Intravenous infusions of vasopressor provide more controlled blood pressure management, but are not always convenient 7 . A number of authors have also recommended intramuscular (IM) injections [7] [8] [9] [10] .
To provide a better perspective on the effectiveness of these different methods of administration, we performed a study that compared the blood pressure profiles resulting from different methods of vasopressor administration during SA. We recruited elderly patients undergoing surgery for fractured neck of femur, because they are prone to develop severe hypotension during spinal anaesthesia 11 . Metaraminol was our chosen vasopressor because it is commonly used in the Asia-Pacific region and we had used it in a number of previous studies 6, 12, 13 .
METHODS
Local ethical committee approval for the study and informed patient consent were obtained. Fifty-four elderly, ASA 1 and 2, Chinese patients scheduled for surgery on their fractured neck of femur were recruited. Patients with severe cardiac disease, irregular heart rhythms or those taking medications such as digoxin or β-blockers that could alter the normal response to treatment were excluded. All patients received a crystalloid intravenous infusion on the ward preoperatively to prevent dehydration and hypovolaemia. Surgery was performed on the second to fourth day following admission, unless delayed for some medical reason.
On arrival in the operating theatre it was established that IV access was adequate and routine cardiovascular monitoring was attached. This included one-minute non-invasive arterial blood pressure (BP), electrocardiogram and pulse oximetry. Following a five-minute period of stabilization, baseline haemodynamic data were recorded. Baseline systolic arterial pressure (SAP) was defined using the mean of three consecutive BP readings. During the study SAP was maintained between limits of 75% to 100% of baseline. If the baseline SAP exceeded 160 mmHg, a baseline value of 160 mmHg was used. Once baseline data collection had been completed, the patient was turned lateral with the fractured hip dependent. Nitrous oxide 50 to 70% in oxygen was given via a facemask, circle and absorber breathing circuit for analgesia during positioning and during spinal puncture. Using a sterile technique, bupivacaine 0.5% heavy solution (Marcain Spinal 0.5% Heavy, Astra, North Ryde, N.S.W., Australia) was injected intrathecally over 5 to 10 seconds at the L3/4 lumbar spinal interspace. Males received 2.7 to 3.0 ml and females 2.4 to 2.7 ml depending on their size and general condition. The nitrous oxide was then stopped and after five minutes the patient was positioned on the operating table for reduction of the fracture, if required, and surgery.
The patients were allocated prior to the study to one of three groups, using sequentially numbered randomized data collection forms. Groups were (a) IM metaraminol, (b) metaraminol IV infusion and (c) rescue boluses of IV metaraminol. Patients in the IM group received, once the spinal had been performed, an injection of metaraminol (0.1 mg.kg -1 ) in the thigh muscle of the non-traumatized leg. Patients in the rescue group received no metaraminol prophylaxis. If the SAP decreased below the designated threshold below baseline SAP on two consecutive occasions, an IV bolus of metaraminol 0.01 mg.kg -1 was given. Patients in the infusion group received an IV bolus of metaraminol 0.01 mg.kg -1 followed by a continuous infusion at 0.05 mg.kg -1 .h -1 which was started, using a syringe pump and dedicated intravenous line, once the spinal had been performed. A mixture of 0.1 mg.kg -1 of metaraminol in 20 ml of normal saline run at 10 ml.h -1 was used. If SAP decreased below the designated level for treatment on two consecutive occasions, the rate was doubled, and if SAP increased above the baseline level on two consecutive occasions the rate was halved. If SAP was deemed clinically to be excessively high, the infusion was stopped.
All patients also received a rapid infusion of 10 ml.kg -1 of normal saline over the first five minutes of spinal anaesthesia, and then normal saline at 100 ml.h -1 . Patients were managed perioperatively by one of two investigators (LC, SY) and intraoperative blood and fluid losses were replaced at the discretion of this study anaesthetist.
During anaesthesia and surgery haemodynamic data were continuously recorded from the anaesthetic machine and built-in monitors using a communication cable connected to a Macintosh laptop computer. A software package developed in our department and used in other recent studies 6, 13 was used to record and display this data (Monitor, version 1.0). Recordings were marked with events such as intrathecal injection and treatment intervention. All other data were recorded on a separate data collection form.
Data collected by patient monitors were processed into five-second epochs and stored using a data acquisition program (Monitor). This program also provided a real-time graphical display of haemodynamic variables that assisted with management of the blood pressure. To facilitate data analysis the monitor files were exported into Microsoft Excel 97. Data were transformed into values for baseline, lateral positioning (and administration of nitrous oxide) and then each five-minute interval following the start of spinal anaesthesia. Baseline data were collected over five minutes and lateral data were collected over the three minutes just prior to SA. Median values for SAP, mean and diastolic arterial pressures (MAP and DAP respectively) and heart rate were used. This format made data handling more manageable and the use of median values reduced the effects of outliers and aberrant measurements.
Percentage changes with respect to baseline for lateral positioning, including inhalation of nitrous oxide, and five-minute interval data were calculated for SAP, MAP, DAP and heart rate. Only the first 60 minutes of spinal anaesthesia was used for our analysis. Percentage data from the three groups were compared using analysis of variance (ANOVA) for repeated measures. Mean and standard error graphs were plotted ( Figure 1 ). We also compared the interquartile ranges (25th to 75th percentiles) and the variances of these data, which were analysed over 10 to 60 minutes. Box plots were used to show the variability in the SAP response to each of the three treatment methods ( Figure 2 ). The total percentage time between 10 and 60 minutes that SAP strayed outside our modified limits of 75 to 100% of baseline was calculated for each group.
In the IM group, the percentage BP profiles (SAP) from each patient were analysed for peak increase, time to peak increase and duration of increase. The latter was determined by measuring the time taken for SAP to fall back to its initial trough value immediately following spinal anaesthesia.
Statistical analysis was performed using StatView for Windows, Version 4.5 (Abacus Concepts, Berkeley, CA, U.S.A.). Patient demographic data were compared using analysis of variance (ANOVA) and Chi square. Haemodynamic data were analysed using ANOVA and F-test. Results are presented as mean (SD or range), unless stated otherwise. P<0.05 was considered significant.
RESULTS
Data from 52 of the original 54 patients were included in the final analysis. One patient in the rescue IV group inadvertently received IM metaraminol and was reassigned to the intramuscular group and two patients were excluded due to failure to perform satisfactory spinal block.
Patients in the three groups were similar with respect to age, weight, gender, ASA status and number with hypertension (including treated/ untreated) ( Table 1) . Antihypertensive medications included nifedipine (eight patients), angiotensinconverting enzyme inhibitors (one patient), thiazide diuretics (three patients) and methyldopa (three patients). Doses of intrathecal bupivacaine (2.7 (2.4-3.0) ml) were similar between groups (Table 1) , as was patient surgery, which lasted 60 to 148 minutes and involved either closed reduction with hip screws (two cases), Austin-Moore arthroplasty (22 cases), Dynamic hip screw (24 cases) or Gamma nail (four cases). Baseline haemodynamic data for the three groups are shown in Table 2 . Patients in the IM group had lower baseline blood pressures (P<0.05) ( Table 2 ).
The effects of the three treatment regimens on BP and heart rate during the first 60 minutes of spinal anaesthesia are shown in Figure 1 . Percentage changes with respect to baseline are used. The first five minutes of spinal anaesthesia were characterized by similar decreases in BP across the three groups (Figure 1 ). These were a decrease of SAP by 15 (14)%, MAP by 17 (16)% and DAP by 35 (15)%, that of the DAP being greatest (P<0.001). Subsequently, IM metaraminol restored and then maintained blood pressures at a mean higher level (3% below baseline) than either the infusion or the rescue regimens (20% below baseline) (P<0.001) ( Table 3) . During the first 10 to 60 minutes of spinal anaesthesia, the SAP exceeded baseline values for 45 (28)%, 6 (11)% and 3 (6)% of this time period in the IM, rescue and infusion groups, respectively and fell below 75% of baseline values for 7 (9)%, 17 (20) % and 20 (20)% of this time period. Heart rate decreased in all groups (P<0.001) and this decrease was greatest in the infusion group (P=0.02) ( Figure 1 ).
The range of patient responses to treatment is shown in the box plots of SAP ( Figure 2) . Mean, 25th-75th centiles, 95% confidence intervals and extreme (outliers) values are plotted at 5-minute intervals for the first 60 minutes of spinal anaesthesia. Patients in the IM group had the greatest, and those in the infusion group the least, between-subject variability (P<0.005). The overall variability is summarised using the inter-quartile range and variance of the percentage change data for SAP and DAP ( Table 4 ).
Analysis of BP profiles in the IM group showed that SAP reached a mean (range) peak value with respect to baseline of +16 (-14 to +57)% after 22 (10 to 40) minutes and remained above the initial trough value for 53 (35 to 70) minutes.
During the first 60 minutes of spinal anaesthesia, (14) Values are mean (SD). SAP=systolic arterial pressure; MAP=mean arterial pressure; DAP=diastolic arterial pressure. Arterial pressures in the intramuscular group were significantly lower than the infusion and rescue groups. (*P<0.05, **P<0.01) 
DISCUSSION
This study found that metaraminol, whether given IM, or IV, is an effective drug for maintaining blood pressure during spinal anaesthesia in the elderly hip fracture patient. However, BP control varied greatly between patients and this was reflected in a wide range of BP responses. In the IM group where 0.1 mg.kg -1 of metaraminol, or 5 mg per 50 kg adult, was given, the blood pressure response was especially unpredictable. Systolic BP was above baseline SAPs for nearly half (45%) of the first hour of the spinal anaesthesia, yet six of 19 patients still required rescue treatment. IV administration of metaraminol was more reliable, the infusion regimen being more predictable ( Figure 2 ). The study also showed a larger than expected decrease in DAP (35%) immediately following the induction of spinal anaesthesia.
This study followed a similar design to that used by us in a previous study 13 , in which we also compared three different treatment regimens used to maintain blood pressure in elderly hip fracture patients. The sample size of 18 per group was based on our experience from previous studies 5, 12, 13 , because an appropriate prior power analysis could not be applied to the type of data being studied 14 . Non-invasive blood pressure measurements, recorded at oneminute intervals, were used, rather than intra-arterial monitoring, because non-invasive measurements are reliable when assessing BP changes during this type of spinal study 5, 6, [11] [12] [13] . We also modified our target blood pressures to include a ceiling value of 160 mmHg for SAP, aiming to reduce treatment related hypertension. Fractured neck of femur patients are commonly hypertensive with baseline SAP above 160 mmHg due to fracture pain and stress 13 , leading to an over-estimation of baseline SAP.
When analysing our data, we were aware of the need to show the variation in patient response to treatment, which is not well illustrated when using conventional blood pressure against time plots (Figure 1 ). Previous authors had largely ignored inter-subject variability in their analyses 7, 9, 10 . We therefore used box plots to show the variability in patient response (Figure 2 ) and compared the inter-quartile range and variance of blood pressure readings ( Table 4 ).
The role of vasopressors, when managing hypotension during spinal anaesthesia, was reviewed by Morgan in 1994 15 . In the non-obstetric patient, Morgan considered ephedrine to be the ideal agent because it possessed both αand β-agonist activity and was therefore capable of increasing both cardiac output and peripheral resistance. However, he did concede that ephedrine caused problems such as cerebral stimulation, increased myocardial irritability, tachycardia and an inconsistent effect. The latter is particularly true in the elderly patient 5, 11 . Methoxamine was the only pure peripheral vasoconstictor reviewed 16, 17 . Regarding delivery route, Morgan concluded that most of the published work involved ephedrine and that the intravenous route was optimal, because absorption from the subcutaneous and intramuscular routes was unreliable. Since 1994, we have published several studies investigating intravenous metaraminol and ephedrine during spinal anaesthesia in the elderly 5, 6, [11] [12] [13] 18 . Metaraminol infusions are highly effective at maintaining BP, but can cause excessive hypertension 12, 18 . Ephedrine infusions are less effective, requiring the patients to be adequately volume loaded 5 . Intramuscular ephedrine (0.5 mg.kg -1 ) in elderly fractured neck of femur patients was effective in 13 of 20 patients 13 and the increase in heart rate was 7 (12)%. Other authors have also studied IM ephedrine. During spinal anaesthesia in obstetric patients, IM ephedrine 50 mg causes maternal hypertension and impairs umbilical blood gases 19 . In nontraumatized elderly patients, Hemmingsen et al found IM ephedrine (37.5 mg) to be more effective than IV ephedrine (12.5 mg) or placebo and recommending its use, particularly in ASA 3 patients 9 . Sternlo et al also considered IM ephedrine (0.6 mg.kg -1 ) useful at induction of spinal anaesthesia 10 . However, concern has been expressed that IM ephedrine occasionally causes hypertension and tachycardia and that this may be harmful, especially in the presence of ischaemic heart disease 20 . Buggy et al are the only group, to our knowledge, to have studied a pure α-agonist given intramuscularly in elderly fracture neck of femur patients 7 . They compared IV hetastarch (500 ml) with IM methoxamine 10 mg injected 10 minutes prior to spinal anaesthesia and found methoxamine provided greater haemodynamic stability.
In the present study, we have compared different methods of administering metaraminol during spinal anaesthesia. The IM route elevated blood pressures for almost one hour (53 (35 to 70) minutes), although the onset of effect was delayed by up to 10 minutes, thus failing to prevent hypotension during the initial phase of spinal anaesthesia. This delay in onset can be overcome by giving the IM vasopressor before the induction of spinal anaesthesia 7, 8 . However, preemptive IM administration can be problematic in the elderly patient because age-related degenerative changes in the lumbar spine may lead to a delay in injecting the local anaesthetic intrathecally and thus cause unanticipated pre-spinal hypertension.
In the present study, IM administration of metaraminol produced a greater than desired elevation in blood pressure. This can be explained by our choice of IM dose of 5 mg per 50 kg, because patients in the two IV groups received less than 3 mg per 50 kg adult. We based this choice on a pilot study in which 5 mg per 50 kg adult, or 0.1 mg.kg -1 , restored blood pressures to baseline levels. Unfortunately, no allowance was made for the large variation in patient response. However, a reduction in dose would lead to a significant number of patients being under treated. Previously, using IM ephedrine 0.5 mg.kg -1 in elderly trauma patients, we found that seven of 20 required additional ephedrine 13 , and Buggy et al using IM methoxamine reported that 27% of patients required additional methoxamine 9 . Thus, a more rational approach to using IM metaraminol during spinal anaesthesia would be a lower dose (perhaps 2.5 mg per 50 kg adult), hoping to avoid unwanted hypertension, and to supplement with IV boluses of metaraminol when necessary.
The variability in BP response to IM metaraminol presumably arises from both pharmacokinetic and dynamic differences between patients. Previously we have questioned variation in the end organ response with respect to IV ephedrine in elderly patients 5 . Drug uptake from the injection site would seem to be an additional source of variability, particularly if the patient is thin and frail, hypovolaemic or distressed.
IV administration provided more predictable, if lower, BP control. As expected, infusions caused the least variability in target BP. However, the pharmacokinetic profile of metaraminol may be of relevance. Short-acting vasopressors such as metaraminol 6 may be more appropriately delivered by infusion because we noted that it was difficult to avoid peak and trough effects with IV bolusing. However, vasopressors with longer durations of action such a dihydroergotamine 21 and possibly ephedrine, may be more suitable as IV boluses. Whether prophylactic metaraminol is necessary in the fractured neck of femur patient undergoing spinal anaesthesia is debatable. Though acute decreases in BP seem undesirable, such episodes have not been shown to be detrimental. Nevertheless, the predictability of BP control provided by metaraminol infusion would appear advantageous.
The large decrease in DAP (35%) following spinal anaesthesia was unexpected. Large decreases in DAP can be potentially harmful, because DAP plays an important role in the coronary circulation and abnormally low pressures may cause myocardial ischaemia and even cardiac arrest 22 . Metaraminol restored the DAP to acceptable levels. Metaraminol acts mainly by constricting the arteries, drawing us to conclude that the decrease in DAP was secondary to arterial vasodilation and decreased peripheral resistance following spinal anaesthesia. Further studies that assess the changes in DAP after treatments that do not constrict the vasculature, such as intravenous fluid, would be of interest.
In conclusion, blood pressure in the traumatized elderly patient receiving spinal anaesthesia can be effectively managed using IV metaraminol, preferably by continuous infusion. The intramuscular route using a dose of 5 mg per 50 kg body weight is not recommended, although it is possible lower IM doses supplemented by IV boluses may have a role. Diastolic blood pressure can fall dramatically following spinal block and the significance of this observation needs further investigation.
